July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Analysis of Retinal Blood Flow in Diabetic Retinopathy Patients with or without Metformin Treatment
Author Affiliations & Notes
  • Jacob Diskin
    Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States
    Wayne State University School of Medicine, Detroit, Michigan, United States
  • Yue Li
    Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States
  • Paul A Edwards
    Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States
  • Hua Gao
    Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States
  • Xiaoxi Qiao
    Ophthalmology, Henry Ford Health System, Detroit, Michigan, United States
  • Footnotes
    Commercial Relationships   Jacob Diskin, None; Yue Li, None; Paul Edwards, None; Hua Gao, None; Xiaoxi Qiao, None
  • Footnotes
    Support  Alliance for Vision Research Award
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1929. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jacob Diskin, Yue Li, Paul A Edwards, Hua Gao, Xiaoxi Qiao; Analysis of Retinal Blood Flow in Diabetic Retinopathy Patients with or without Metformin Treatment. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1929.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Metabolic alterations in diabetes can affect retinal blood flow. In this study, we investigate whether metformin use is associated with changes on retinal blood flow in diabetic retinopathy (DR) patients regardless of HbA1c level.

Methods : This is a retrospective study of patients with longstanding type 2 diabetes. Patients with type 2 diabetes for more than 15 years were included. Patients were included if they never used metformin or used metformin for at least 5 years prior to onset of diabetic retinopathy. Patients without ophthalmic or primary care records were excluded. Fluorescein angiography records were reviewed and analyzed for artery, vein and capillary perfusion time, and the distribution of microaneurysms.

Results : Eighty patients with diabetic retinopathy are included in the current analysis, 53 patients on metformin and 27 patients not on metformin. In the metformin group, there are 34, 3, and 16 of patients with mild, moderate, and severe diabetic retinopathy, while in the non-metformin group, there are 12, 3, and 12, respectively. Preliminary analysis of venous perfusion time in 15 patients with mild and moderate non-proliferative DR from each group revealed faster average venous filling time in metformin group comparing with that in non-metformin group (8.35 seconds versus 10.2 seconds). A gross estimate of microaneurysm distribution in 4 quadrants showed less microaneurysms in metformin group (3.26) versus in non-metformin group (3.86).

Conclusions : These preliminary results suggest that metformin treatment may improve retinal venous perfusion, and reduce microaneurysm distributions in diabetic retinopathy patients.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×